Segment disclosures

Company overview

Petros Pharmaceuticals, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 70 retained observations 21 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Operating Segments · Medical Device Sales

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ptpi:MedicalDeviceSalesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-313150752 USD20250331Open filing evidence
2024-07-01 – 2024-09-30718303 USD20250124Open filing evidence
2024-01-01 – 2024-09-302300460 USD20250124Open filing evidence
2024-04-01 – 2024-06-30806449 USD20240814Open filing evidence
2024-01-01 – 2024-06-301582161 USD20240814Open filing evidence
2024-01-01 – 2024-03-31775711 USD20240515Open filing evidence
2023-01-01 – 2023-12-313536015 USD20250331Open filing evidence
2023-07-01 – 2023-09-30748898 USD20250124Open filing evidence
2023-01-01 – 2023-09-302770194 USD20250124Open filing evidence
2023-04-01 – 2023-06-301009603 USD20240814Open filing evidence
2023-01-01 – 2023-06-302021297 USD20240814Open filing evidence
2023-01-01 – 2023-03-311011694 USD20240515Open filing evidence
2022-01-01 – 2022-12-313257415 USD20240401Open filing evidence
2022-04-01 – 2022-06-30854343 USD20230814Open filing evidence
2022-01-01 – 2022-06-301794744 USD20230814Open filing evidence

Operating Segments · Prescription Medication Sales

Consolidation Items · Statement Business Segments

Source dimensions srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=ptpi:PrescriptionMedicationSalesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-311961291 USD20250331Open filing evidence
2024-07-01 – 2024-09-30858063 USD20250124Open filing evidence
2024-01-01 – 2024-09-302086180 USD20250124Open filing evidence
2024-04-01 – 2024-06-30615022 USD20240814Open filing evidence
2024-01-01 – 2024-06-301228115 USD20240814Open filing evidence
2024-01-01 – 2024-03-31613095 USD20240515Open filing evidence
2023-01-01 – 2023-12-312286373 USD20250331Open filing evidence
2023-07-01 – 2023-09-30925759 USD20250124Open filing evidence
2023-01-01 – 2023-09-303416444 USD20250124Open filing evidence
2023-04-01 – 2023-06-30984408 USD20240814Open filing evidence
2023-01-01 – 2023-06-302490686 USD20240814Open filing evidence
2023-01-01 – 2023-03-311506278 USD20240515Open filing evidence
2022-01-01 – 2022-12-312734639 USD20240401Open filing evidence
2022-04-01 – 2022-06-303332173 USD20230814Open filing evidence
2022-01-01 – 2022-06-304856941 USD20230814Open filing evidence

Medical Device Sales

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ptpi:MedicalDeviceSalesMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-311011693 USD20230515Open filing evidence
2022-01-01 – 2022-12-313257415 USD20230331Open filing evidence
2022-07-01 – 2022-09-30682897 USD20221115Open filing evidence
2022-01-01 – 2022-09-302477642 USD20221115Open filing evidence
2022-04-01 – 2022-06-30854343 USD20220812Open filing evidence
2022-01-01 – 2022-06-301794744 USD20220812Open filing evidence
2022-01-01 – 2022-03-31940401 USD20230515Open filing evidence
2021-01-01 – 2021-12-313206221 USD20230331Open filing evidence
2021-07-01 – 2021-09-30767878 USD20221115Open filing evidence
2021-01-01 – 2021-09-302450671 USD20221115Open filing evidence
2021-04-01 – 2021-06-30807834 USD20220812Open filing evidence
2021-01-01 – 2021-06-301682793 USD20220812Open filing evidence
2021-01-01 – 2021-03-31874959 USD20220516Open filing evidence
2020-01-01 – 2020-12-313201971 USD20220331Open filing evidence
2020-07-01 – 2020-09-30874544 USD20220106Open filing evidence
2020-01-01 – 2020-09-302501486 USD20220106Open filing evidence
2020-04-01 – 2020-06-30633278 USD20210816Open filing evidence
2020-01-01 – 2020-06-301626942 USD20210816Open filing evidence
2020-01-01 – 2020-03-31993664 USD20210514Open filing evidence
2019-01-01 – 2019-12-314466506 USD20220106Open filing evidence

Prescription Medication Sales

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ptpi:PrescriptionMedicationSalesMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-311506278 USD20230515Open filing evidence
2022-01-01 – 2022-12-312734639 USD20230331Open filing evidence
2022-07-01 – 2022-09-30-2140629 USD20221115Open filing evidence
2022-01-01 – 2022-09-302716311 USD20221115Open filing evidence
2022-04-01 – 2022-06-303332173 USD20220812Open filing evidence
2022-01-01 – 2022-06-304856941 USD20220812Open filing evidence
2022-01-01 – 2022-03-311524768 USD20230515Open filing evidence
2021-01-01 – 2021-12-314605043 USD20230331Open filing evidence
2021-07-01 – 2021-09-301377291 USD20221115Open filing evidence
2021-01-01 – 2021-09-306227753 USD20221115Open filing evidence
2021-04-01 – 2021-06-301649815 USD20220812Open filing evidence
2021-01-01 – 2021-06-304850462 USD20220812Open filing evidence
2021-01-01 – 2021-03-313200647 USD20220516Open filing evidence
2020-01-01 – 2020-12-316357498 USD20220331Open filing evidence
2020-07-01 – 2020-09-302590151 USD20220106Open filing evidence
2020-01-01 – 2020-09-304128694 USD20220106Open filing evidence
2020-04-01 – 2020-06-30740286 USD20210816Open filing evidence
2020-01-01 – 2020-06-301538543 USD20210816Open filing evidence
2020-01-01 – 2020-03-31798257 USD20210514Open filing evidence
2019-01-01 – 2019-12-3111110660 USD20220106Open filing evidence